カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の慢性心不全(CHF)治療薬市場2022年：抗凝固薬（アスピリン）、抗血小板薬（クロピドグレル、プラスグレル、チカグレロル）、抗凝固薬（ワルファリン）、血圧維持薬（アンジオテンシン変換酵素（ACE）阻害剤）、アンジオテンシンII受容体遮断薬（ARB）、スタチン、利尿薬、硝酸塩

◆英語タイトル：Global Chronic Heart Failure (CHF) Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8767 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：101 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

慢性心不全(CHF)治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の慢性心不全(CHF)治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

慢性心不全(CHF)治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・抗凝固薬（アスピリン）、抗血小板薬（クロピドグレル、プラスグレル、チカグレロル）、抗凝固薬（ワルファリン）、血圧維持薬（アンジオテンシン変換酵素（ACE）阻害剤）、アンジオテンシンII受容体遮断薬（ARB）、スタチン、利尿薬、硝酸塩

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界の慢性心不全(CHF)治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Abbott、Johnson & Johnson、Merck、Stanley Pharmaceuticals、New Haven Pharmaceuticals, Inc.、Pfizer、GlaxoSmithKline plc、Novartis International AG、Biovail Corporation、Bristol-Myers Squibb Company、Symplmed Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、慢性心不全(CHF)治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な慢性心不全(CHF)治療薬メーカーの企業概要、2019年～2022年までの慢性心不全(CHF)治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な慢性心不全(CHF)治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別慢性心不全(CHF)治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの慢性心不全(CHF)治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での慢性心不全(CHF)治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および慢性心不全(CHF)治療薬の産業チェーンを掲載しています。
・第13、14、15章では、慢性心不全(CHF)治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Johnson & Johnson、Merck、Stanley Pharmaceuticals、New Haven Pharmaceuticals, Inc.、Pfizer、GlaxoSmithKline plc、Novartis International AG、Biovail Corporation、Bristol-Myers Squibb Company、Symplmed Pharmaceuticals
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：抗凝固薬（アスピリン）、抗血小板薬（クロピドグレル、プラスグレル、チカグレロル）、抗凝固薬（ワルファリン）、血圧維持薬（アンジオテンシン変換酵素（ACE）阻害剤）、アンジオテンシンII受容体遮断薬（ARB）、スタチン、利尿薬、硝酸塩
・用途別分析2017年-2028年：病院、クリニック、その他
・慢性心不全(CHF)治療薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・慢性心不全(CHF)治療薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・慢性心不全(CHF)治療薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・慢性心不全(CHF)治療薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・慢性心不全(CHF)治療薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Chronic Heart Failure (CHF) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Chronic Heart Failure (CHF) Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Chronic Heart Failure (CHF) Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-clotting (Aspirin) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Chronic Heart Failure (CHF) Drugs include Abbott, Johnson & Johnson, Merck, Stanley Pharmaceuticals, and New Haven Pharmaceuticals, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Chronic Heart Failure (CHF) Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-clotting (Aspirin)
Antiplatelet Medicines (Clopidogrel, Prasugrel, and Ticagrelor)
Anticoagulant Medicines (Warfarin)
Blood Pressure Maintaining Agents (Angiotensin Converting Enzyme (ACE) Inhibitors)
Angiotensin II Receptor Blockers (ARB)
Statins
Diuretics
Nitrates
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Chronic Heart Failure (CHF) Drugs market are listed below:
Abbott
Johnson & Johnson
Merck
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Pfizer
GlaxoSmithKline plc
Novartis International AG
Biovail Corporation
Bristol-Myers Squibb Company
Symplmed Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Heart Failure (CHF) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Heart Failure (CHF) Drugs, with price, sales, revenue and global market share of Chronic Heart Failure (CHF) Drugs from 2019 to 2022.
Chapter 3, the Chronic Heart Failure (CHF) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Heart Failure (CHF) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Chronic Heart Failure (CHF) Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Heart Failure (CHF) Drugs.
Chapter 13, 14, and 15, to describe Chronic Heart Failure (CHF) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Chronic Heart Failure (CHF) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Heart Failure (CHF) Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Anti-clotting (Aspirin)
1.2.3 Antiplatelet Medicines (Clopidogrel, Prasugrel, and Ticagrelor)
1.2.4 Anticoagulant Medicines (Warfarin)
1.2.5 Blood Pressure Maintaining Agents (Angiotensin Converting Enzyme (ACE) Inhibitors)
1.2.6 Angiotensin II Receptor Blockers (ARB)
1.2.7 Statins
1.2.8 Diuretics
1.2.9 Nitrates
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Heart Failure (CHF) Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Chronic Heart Failure (CHF) Drugs Market Size & Forecast
1.4.1 Global Chronic Heart Failure (CHF) Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Chronic Heart Failure (CHF) Drugs Sales in Volume (2017-2028)
1.4.3 Global Chronic Heart Failure (CHF) Drugs Price (2017-2028)
1.5 Global Chronic Heart Failure (CHF) Drugs Production Capacity Analysis
1.5.1 Global Chronic Heart Failure (CHF) Drugs Total Production Capacity (2017-2028)
1.5.2 Global Chronic Heart Failure (CHF) Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chronic Heart Failure (CHF) Drugs Market Drivers
1.6.2 Chronic Heart Failure (CHF) Drugs Market Restraints
1.6.3 Chronic Heart Failure (CHF) Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Chronic Heart Failure (CHF) Drugs Product and Services
2.1.4 Abbott Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Chronic Heart Failure (CHF) Drugs Product and Services
2.2.4 Johnson & Johnson Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Chronic Heart Failure (CHF) Drugs Product and Services
2.3.4 Merck Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Stanley Pharmaceuticals
2.4.1 Stanley Pharmaceuticals Details
2.4.2 Stanley Pharmaceuticals Major Business
2.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product and Services
2.4.4 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 New Haven Pharmaceuticals, Inc.
2.5.1 New Haven Pharmaceuticals, Inc. Details
2.5.2 New Haven Pharmaceuticals, Inc. Major Business
2.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Product and Services
2.5.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Chronic Heart Failure (CHF) Drugs Product and Services
2.6.4 Pfizer Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GlaxoSmithKline plc
2.7.1 GlaxoSmithKline plc Details
2.7.2 GlaxoSmithKline plc Major Business
2.7.3 GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Product and Services
2.7.4 GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis International AG
2.8.1 Novartis International AG Details
2.8.2 Novartis International AG Major Business
2.8.3 Novartis International AG Chronic Heart Failure (CHF) Drugs Product and Services
2.8.4 Novartis International AG Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biovail Corporation
2.9.1 Biovail Corporation Details
2.9.2 Biovail Corporation Major Business
2.9.3 Biovail Corporation Chronic Heart Failure (CHF) Drugs Product and Services
2.9.4 Biovail Corporation Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Bristol-Myers Squibb Company
2.10.1 Bristol-Myers Squibb Company Details
2.10.2 Bristol-Myers Squibb Company Major Business
2.10.3 Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Product and Services
2.10.4 Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Symplmed Pharmaceuticals
2.11.1 Symplmed Pharmaceuticals Details
2.11.2 Symplmed Pharmaceuticals Major Business
2.11.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product and Services
2.11.4 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Chronic Heart Failure (CHF) Drugs Breakdown Data by Manufacturer
3.1 Global Chronic Heart Failure (CHF) Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Chronic Heart Failure (CHF) Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Chronic Heart Failure (CHF) Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Chronic Heart Failure (CHF) Drugs Manufacturer Market Share in 2021
3.5 Global Chronic Heart Failure (CHF) Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Chronic Heart Failure (CHF) Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chronic Heart Failure (CHF) Drugs Market Size by Region
4.1.1 Global Chronic Heart Failure (CHF) Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2028)
4.2 North America Chronic Heart Failure (CHF) Drugs Revenue (2017-2028)
4.3 Europe Chronic Heart Failure (CHF) Drugs Revenue (2017-2028)
4.4 Asia-Pacific Chronic Heart Failure (CHF) Drugs Revenue (2017-2028)
4.5 South America Chronic Heart Failure (CHF) Drugs Revenue (2017-2028)
4.6 Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Chronic Heart Failure (CHF) Drugs Sales in Volume by Type (2017-2028)
5.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028)
5.3 Global Chronic Heart Failure (CHF) Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Chronic Heart Failure (CHF) Drugs Sales in Volume by Application (2017-2028)
6.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028)
6.3 Global Chronic Heart Failure (CHF) Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
7.2 North America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
7.3 North America Chronic Heart Failure (CHF) Drugs Market Size by Country
7.3.1 North America Chronic Heart Failure (CHF) Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
8.2 Europe Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
8.3 Europe Chronic Heart Failure (CHF) Drugs Market Size by Country
8.3.1 Europe Chronic Heart Failure (CHF) Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Chronic Heart Failure (CHF) Drugs Market Size by Region
9.3.1 Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
10.2 South America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
10.3 South America Chronic Heart Failure (CHF) Drugs Market Size by Country
10.3.1 South America Chronic Heart Failure (CHF) Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Chronic Heart Failure (CHF) Drugs Market Size by Country
11.3.1 Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Chronic Heart Failure (CHF) Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Chronic Heart Failure (CHF) Drugs
12.3 Chronic Heart Failure (CHF) Drugs Production Process
12.4 Chronic Heart Failure (CHF) Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Chronic Heart Failure (CHF) Drugs Typical Distributors
13.3 Chronic Heart Failure (CHF) Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Chronic Heart Failure (CHF) Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Chronic Heart Failure (CHF) Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Chronic Heart Failure (CHF) Drugs Product and Services
Table 6. Abbott Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Chronic Heart Failure (CHF) Drugs Product and Services
Table 10. Johnson & Johnson Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Chronic Heart Failure (CHF) Drugs Product and Services
Table 14. Merck Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Stanley Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Stanley Pharmaceuticals Major Business
Table 17. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product and Services
Table 18. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. New Haven Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. New Haven Pharmaceuticals, Inc. Major Business
Table 21. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Product and Services
Table 22. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Chronic Heart Failure (CHF) Drugs Product and Services
Table 26. Pfizer Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline plc Major Business
Table 29. GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Product and Services
Table 30. GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 32. Novartis International AG Major Business
Table 33. Novartis International AG Chronic Heart Failure (CHF) Drugs Product and Services
Table 34. Novartis International AG Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Biovail Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Biovail Corporation Major Business
Table 37. Biovail Corporation Chronic Heart Failure (CHF) Drugs Product and Services
Table 38. Biovail Corporation Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 40. Bristol-Myers Squibb Company Major Business
Table 41. Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Product and Services
Table 42. Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Symplmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Symplmed Pharmaceuticals Major Business
Table 45. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product and Services
Table 46. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Chronic Heart Failure (CHF) Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 48. Global Chronic Heart Failure (CHF) Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Chronic Heart Failure (CHF) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Chronic Heart Failure (CHF) Drugs Production Capacity by Company, (Kg): 2020 VS 2021
Table 51. Head Office and Chronic Heart Failure (CHF) Drugs Production Site of Key Manufacturer
Table 52. Chronic Heart Failure (CHF) Drugs New Entrant and Capacity Expansion Plans
Table 53. Chronic Heart Failure (CHF) Drugs Mergers & Acquisitions in the Past Five Years
Table 54. Global Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2022) & (Kg)
Table 55. Global Chronic Heart Failure (CHF) Drugs Sales by Region (2023-2028) & (Kg)
Table 56. Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg)
Table 59. Global Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg)
Table 60. Global Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Chronic Heart Failure (CHF) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Chronic Heart Failure (CHF) Drugs Price by Type (2017-2022) & (USD/g)
Table 63. Global Chronic Heart Failure (CHF) Drugs Price by Type (2023-2028) & (USD/g)
Table 64. Global Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg)
Table 65. Global Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg)
Table 66. Global Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Chronic Heart Failure (CHF) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Chronic Heart Failure (CHF) Drugs Price by Application (2017-2022) & (USD/g)
Table 69. Global Chronic Heart Failure (CHF) Drugs Price by Application (2023-2028) & (USD/g)
Table 70. North America Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2022) & (Kg)
Table 71. North America Chronic Heart Failure (CHF) Drugs Sales by Country (2023-2028) & (Kg)
Table 72. North America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Chronic Heart Failure (CHF) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg)
Table 75. North America Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg)
Table 76. North America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg)
Table 77. North America Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg)
Table 78. Europe Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2022) & (Kg)
Table 79. Europe Chronic Heart Failure (CHF) Drugs Sales by Country (2023-2028) & (Kg)
Table 80. Europe Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Chronic Heart Failure (CHF) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg)
Table 83. Europe Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg)
Table 84. Europe Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg)
Table 85. Europe Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg)
Table 86. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2022) & (Kg)
Table 87. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales by Region (2023-2028) & (Kg)
Table 88. Asia-Pacific Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Chronic Heart Failure (CHF) Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg)
Table 91. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg)
Table 92. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg)
Table 93. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg)
Table 94. South America Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2022) & (Kg)
Table 95. South America Chronic Heart Failure (CHF) Drugs Sales by Country (2023-2028) & (Kg)
Table 96. South America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Chronic Heart Failure (CHF) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg)
Table 99. South America Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg)
Table 100. South America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg)
Table 101. South America Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg)
Table 102. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2022) & (Kg)
Table 103. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales by Region (2023-2028) & (Kg)
Table 104. Middle East & Africa Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Chronic Heart Failure (CHF) Drugs Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg)
Table 107. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg)
Table 108. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg)
Table 109. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg)
Table 110. Chronic Heart Failure (CHF) Drugs Raw Material
Table 111. Key Manufacturers of Chronic Heart Failure (CHF) Drugs Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Chronic Heart Failure (CHF) Drugs Typical Distributors
Table 115. Chronic Heart Failure (CHF) Drugs Typical Customers
List of Figures
Figure 1. Chronic Heart Failure (CHF) Drugs Picture
Figure 2. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type in 2021
Figure 3. Anti-clotting (Aspirin)
Figure 4. Antiplatelet Medicines (Clopidogrel, Prasugrel, and Ticagrelor)
Figure 5. Anticoagulant Medicines (Warfarin)
Figure 6. Blood Pressure Maintaining Agents (Angiotensin Converting Enzyme (ACE) Inhibitors)
Figure 7. Angiotensin II Receptor Blockers (ARB)
Figure 8. Statins
Figure 9. Diuretics
Figure 10. Nitrates
Figure 11. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application in 2021
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Chronic Heart Failure (CHF) Drugs Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 16. Global Chronic Heart Failure (CHF) Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Chronic Heart Failure (CHF) Drugs Sales (2017-2028) & (Kg)
Figure 18. Global Chronic Heart Failure (CHF) Drugs Price (2017-2028) & (USD/g)
Figure 19. Global Chronic Heart Failure (CHF) Drugs Production Capacity (2017-2028) & (Kg)
Figure 20. Global Chronic Heart Failure (CHF) Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Chronic Heart Failure (CHF) Drugs Market Drivers
Figure 22. Chronic Heart Failure (CHF) Drugs Market Restraints
Figure 23. Chronic Heart Failure (CHF) Drugs Market Trends
Figure 24. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Manufacturer in 2021
Figure 25. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Manufacturer in 2021
Figure 26. Chronic Heart Failure (CHF) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Chronic Heart Failure (CHF) Drugs Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Chronic Heart Failure (CHF) Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Region (2017-2028)
Figure 30. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Region (2017-2028)
Figure 31. North America Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Europe Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (USD Million)
Figure 34. South America Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028)
Figure 37. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028)
Figure 38. Global Chronic Heart Failure (CHF) Drugs Price by Type (2017-2028) & (USD/g)
Figure 39. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028)
Figure 40. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028)
Figure 41. Global Chronic Heart Failure (CHF) Drugs Price by Application (2017-2028) & (USD/g)
Figure 42. North America Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028)
Figure 43. North America Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028)
Figure 44. North America Chronic Heart Failure (CHF) Drugs Sales Market Share by Country (2017-2028)
Figure 45. North America Chronic Heart Failure (CHF) Drugs Revenue Market Share by Country (2017-2028)
Figure 46. United States Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028)
Figure 50. Europe Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028)
Figure 51. Europe Chronic Heart Failure (CHF) Drugs Sales Market Share by Country (2017-2028)
Figure 52. Europe Chronic Heart Failure (CHF) Drugs Revenue Market Share by Country (2017-2028)
Figure 53. Germany Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Chronic Heart Failure (CHF) Drugs Revenue Market Share by Region (2017-2028)
Figure 62. China Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028)
Figure 69. South America Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028)
Figure 70. South America Chronic Heart Failure (CHF) Drugs Sales Market Share by Country (2017-2028)
Figure 71. South America Chronic Heart Failure (CHF) Drugs Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Chronic Heart Failure (CHF) Drugs Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Chronic Heart Failure (CHF) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Chronic Heart Failure (CHF) Drugs in 2021
Figure 83. Manufacturing Process Analysis of Chronic Heart Failure (CHF) Drugs
Figure 84. Chronic Heart Failure (CHF) Drugs Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の慢性心不全(CHF)治療薬市場2022年：抗凝固薬（アスピリン）、抗血小板薬（クロピドグレル、プラスグレル、チカグレロル）、抗凝固薬（ワルファリン）、血圧維持薬（アンジオテンシン変換酵素（ACE）阻害剤）、アンジオテンシンII受容体遮断薬（ARB）、スタチン、利尿薬、硝酸塩(Global Chronic Heart Failure (CHF) Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp